Investing in Avadel Pharmaceuticals plc (AVDL): What You Must Know
Avadel Pharmaceuticals plc’s filing revealed that its Chief Financial Officer MCHUGH THOMAS S acquired Company’s shares for reported $29000.0 on Jan 16 ’24. In the deal valued at $14.50 per share,2,000 shares were bought. As a result of this transaction, MCHUGH THOMAS S now holds 80,500 shares worth roughly $1.37 million. Then, McCamish Mark Anthony […]
Avadel Pharmaceuticals plc ADR [NASDAQ: AVDL] Sees Decrease in Stock Value
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Avadel Pharmaceuticals plc ADR shares valued at $29,000 were purchased by MCHUGH THOMAS S on Jan 16 ’24. At $14.50 per share, MCHUGH THOMAS S acquired 2,000 shares. The insider’s holdings grew to 80,500 shares worth approximately […]
Recent Insider Activity Suggests Potential Gains for Avadel Pharmaceuticals plc ADR (AVDL)
Avadel Pharmaceuticals plc ADR’s recently made public that its Chief Financial Officer MCHUGH THOMAS S acquired Company’s shares for reported $29000.0 on Jan 16 ’24. In the deal valued at $14.50 per share,2,000 shares were bought. As a result of this transaction, MCHUGH THOMAS S now holds 80,500 shares worth roughly $1.38 million. Then, McCamish […]
Avadel Pharmaceuticals plc ADR (AVDL) receives an Outperform rating from Oppenheimer
Avadel Pharmaceuticals plc ADR’s filing revealed that its Chief Financial Officer MCHUGH THOMAS S acquired Company’s shares for reported $29000.0 on Jan 16 ’24. In the deal valued at $14.50 per share,2,000 shares were bought. As a result of this transaction, MCHUGH THOMAS S now holds 80,500 shares worth roughly $1.34 million. Then, McCamish Mark […]
